The overall goal of the research of this collaborative group of faculty is to improve the public’s health and outcomes through the efficient use of scarce health care resources, and to reduce health disparities through practice-, population-, and policy-based research.
Faculty Participants: College of Pharmacy
Dr. Frei’s translational research activities involve the application and critical evaluation of novel technologies (including anti-infectives) in both institutional and community healthcare settings. His approach can best be described as a mixture of pharmacoepidemiology, health services research, health disparities research, and microbial genomics.
Research research interests include economic and outcomes evaluations for several disease states as well as for pharmacy services.
Research interests include: 1) examining the impact of pharmacy services (primarily medication therapy management services) on patient outcomes; 2) understanding factors that affect health care utilization and outcomes; and 3) examining the factors associated with medication adherence.
Research focuses on health care economics, pharmacoeconomics and outcomes research primarily in cancer, but also in other disease areas.
Research research is focused on factors related to the utilization and costs of prescription medications and other health care services. In addition, he is involved in research to evaluate the effects of educational interventions.
Dr. Moczygemba uses qualitative and quantitative techniques and quality improvement principles to assess the clinical, economic, and humanistic impact of emerging care models. She has worked to advance the health care of homeless individuals, older adults, and those living in rural areas through the development, implementation, and evaluation of care models that integrate pharmacists with health care teams.
Dr. Reveles’ research focus is the prevention and treatment of Clostridium difficile infections and innovative methods to improve the translation of clinical research findings into practice.